Project Grant R41MH131449

Award Date 9/7/22
Completion Date 8/31/24
Dollars Obligated $1.3M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will provide $446,490 to Esperimage LLC, a startup company based in Missouri, to develop efficient and flexible data registration and modeling procedures to complement their high-fidelity, wearable optical technology for naturalistic brain imaging. The goal is to create commercialization-ready tools that can enable the use of this technology in pediatric...
This Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $959,066 to Jelikalite Corp. to develop a non-invasive medical device and data platform to improve communication, responsiveness, and social integration for autistic children. The project aims to finalize a prototype wearable device that delivers transcranial photobiomodulation (TPBM) therapy based on integrated electroencephalogram...
The National Science Foundation awarded Jelikalite Corp. a $276,000 Project Grant under the NSF Technology, Innovation, and Partnerships program to develop an EEG-guided transcranial photobiomodulation device for autism treatment. The Small Business Innovation Research Phase I award will support Jelikalite in demonstrating proof of concept for a non-invasive, wearable medical device that stimulates brain tissue with near-infrared radiation. Integrated electroencephalography feedback will monitor...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $208,888 to The Washington University in St. Louis to develop computer vision techniques for identifying autism spectrum disorder (ASD) motor deficits in infants. The key objectives are to: 1) Use the OpenPose algorithm and deep learning to automatically track infant body movements from video data collected during autism behavior assessments; 2)...
The National Science Foundation awarded a $266,000 Project Grant to Columbia University under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a wearable noninvasive brain imaging device using near-infrared light-based time-domain diffuse optical tomography. The device aims to improve clinical outcomes in neurology by enabling measurement of deep brain blood flow, which is difficult to measure with current technologies. The grant will support...
This Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), is focused on developing an advanced technology for non-invasive recording of whole-brain physiology with synchronized video-tracking of movement. The total award amount is $6,311,402.00, with a project period from July 2024 to April 2026. The award has three key objectives: 1) refine and validate the use of a wearable optically-pumped magnetometer...
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $426,234 to Rowan University to pilot a Virtual Reality (VR) parent training tool for managing challenging behaviors in children with autism spectrum disorder (ASD). The key products and services to be delivered include: 1) Refining and testing a customizable, in-home VR training tool that allows parents to practice...
This $1,309,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program supports the development of a novel digital psychiatry diagnostic framework that utilizes crowdsourcing algorithms to improve the specificity of machine learning models in distinguishing between autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in adolescents. The key products and services to be delivered under this 3-year...
This $778,398 National Institute of Mental Health project grant will fund research at the University of California, San Diego to test the accuracy of eye tracking as an early screening tool for autism spectrum disorder (ASD) in the general pediatric population. The research aims to screen approximately 8,000 toddlers ages 12-24 months attending well-baby checkups over the five-year period from May 2023 to March 2028. Researchers will use eye tracking technology to measure social attention...
This National Science Foundation (NSF) Engineering Research Initiation (ERI) project grant, under CFDA 47.041, is awarded for $200,000 to the University of the Pacific to develop a novel wearable sensing and analysis system for early detection of autism spectrum disorder (ASD) in young children and toddlers. The research aims to leverage non-invasive wearable devices to collect physiological and environmental data, and then use machine learning to identify physiological biomarkers and early...

WEARABLE MODULAR HIGH-DENSITY DIFFUSE OPTICAL TOMOGRAPHY - PROJECT SUMMARY: ESPERIMAGE, A STARTUP COMPANY OUT OF WASHINGTON UNIVERSITY (WUSTL), WILL DEVELOP HIGH FIDELITY, WEARABLE, OPTICAL TECHNOLOGY THAT TRANSCENDS LIMITATIONS OF BOTH PREVIOUS OPTICAL NEUROIMAGING AND MAGNETIC RESONANCE IMAGING (MRI) TOOLS TO PROVIDE NATURALISTIC BRAIN IMAGING IN ADULTS AND CHILDREN. A NEURODEVELOPMENTAL DISORDER AFFECTING 1/54 CHILDREN IN THE GENERAL POPULATION, AUTISM SPECTRUM DISORDER (ASD) PRESENTS HIGHLY HETEROGENEOUS PHENOTYPES; HOWEVER, CORE FEATURES ARE IMPAIRED DEVELOPMENT OF SOCIAL-COMMUNICATIVE SKILLS PLUS REPETITIVE BEHAVIORS AND RESTRICTED INTERESTS. ADDITIONALLY, EARLY DIFFICULTIES WITH VISUO-MOTOR INTEGRATION AND MOTOR IMITATION MAY BE STRONGLY ASSOCIATED WITH IMPAIRMENTS OF SOCIAL COMMUNICATION WIDELY REPORTED IN INDIVIDUALS WITH ASD. BECAUSE EARLY INTERVENTIONS IN TODDLERS WITH ASD HAVE BEEN PROVEN TO RESULT IN IMPROVED OUTCOMES, INNOVATIVE METHODS FOR EARLY DETECTION OF THE ALTERATIONS IN BRAIN FUNCTION UNDERLYING ASD PRIOR TO MANIFESTATION OF BEHAVIORAL SYMPTOMS ARE NECESSARY TO ADVANCE TREATMENT STRATEGIES AND IMPROVE PROGNOSES. CURRENT BRAIN MAPPING METHODS SUCH AS FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) OFFER PROMISING SENSITIVITY YET POSE SIGNIFICANT METHODOLOGICAL CHALLENGES IN STUDIES OF AWAKE, INTERACTING, AND MOVING CHILDREN DUE TO THE LOUD, CONSTRAINING ENVIRONMENT AND SUSCEPTIBILITY TO MOTION-INDUCED ARTIFACTS. OPTICAL NEUROIMAGING PROVIDES A POTENTIAL SURROGATE FOR FMRI. HOWEVER, IMAGE QUALITY WITH TRADITIONAL OPTICAL TECHNOLOGY, FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS), SYSTEMS HAD BEEN LACKING IN COMPARISON TO THE GOLD STANDARD OF FMRI. DEVELOPMENT OF HIGH-DENSITY DIFFUSE OPTICAL TOMOGRAPHY (HD-DOT), A TOMOGRAPHIC VERSION OF FNIRS, HAS DRAMATICALLY IMPROVED IMAGE QUALITY, AND MAPS SENSORY, MOTOR, AND COGNITIVE NETWORKS WITH FIDELITY COMPARABLE TO FMRI THROUGHOUT THE OUTER 1 CM OF THE CORTEX. DESPITE THESE ADVANCES, APPLICATION OF HD-DOT TO NATURALISTIC STUDIES IN CHILDREN HAS BEEN LIMITED BY LARGE OPTO-ELECTRONIC CONSOLES AND BULKY FIBER OPTICS. SEVERAL WEARABLE FIBER-LESS FNIRS INSTRUMENTS ARE BECOMING AVAILABLE COMMERCIALLY, BUT ALL HAVE MULTIPLE DEFICITS - EITHER LOWER RESOLUTION, STRONGER IMAGE DISTORTIONS, SMALLER FIELDS OF VIEW, OR LESS SIGNAL TO NOISE THAN PROPOSED HEREIN. THIS PHASE-I STTR PROJECT WILL DEVELOP A COMMERCIALIZATION-READY WHD-DOT DEVICE THAT MATCHES PERFORMANCE OF FIBER-BASED HD-DOT FOR USE IN PEDIATRIC STUDIES INCLUDING ON NEURODEVELOPMENTAL DISORDERS. LONG TERM IMPACT: THE WHD-DOT IMAGING SYSTEMS WILL ENABLE NEUROSCIENCE TO BETTER UNDERSTAND THE MECHANISMS OF DISEASE AS WELL AS MONITOR RESPONSE TO THERAPY IN THE DEVELOPING BRAIN. THE GOAL OF AIM 1 IS TO DEVELOP A ROBUST MODULAR SCALABLE WHD-DOT SYSTEM. THE GOAL OF AIM 2 WILL BE TO VALIDATE THE WHD SYSTEM IN HEALTHY ADULTS AND IN CHILDREN BOTH TYPICAL DEVELOPING AND THOSE WITH ASD. VALIDATION WILL ESTABLISH FEASIBILITY THROUGH MAPPING DISTRIBUTED BRAIN ACTIVITY IN UNTETHERED ADULTS AND CHILDREN. THIS WILL ESTABLISH A FULL-HEAD WHD-DOT PRODUCT FOR COMMERCIALIZATION DEVELOPMENT IN A FOLLOW-UP PHASE-II PROPOSAL.

Posted 9/7/22, 12:00 AM